
U.S. stocks closed higher on Friday, led by the Dow's 300-point gain, after inflation data showed the PCE price index rose 2.7% year-over-year and core PCE remained flat at 2.9%, both matching forecasts and indicating continued Fed caution on rate cuts. Despite this daily rally, major indices posted weekly losses, while Intel Corp. surged over 4% on Friday, extending its weekly gain to approximately 20% due to momentum from Nvidia's $5 billion investment. Market sentiment, as measured by the CNN Fear & Greed index, remained in the "Neutral" zone at 52.8.
U.S. equity markets displayed a divergence between short-term optimism and underlying weekly caution. While major indices closed higher on Friday, with the Dow Jones gaining approximately 300 points, this was insufficient to offset weekly losses across the Dow (-0.2%), S&P 500 (-0.3%), and Nasdaq (-0.7%). The daily rally was catalyzed by the release of August's Personal Consumption Expenditures (PCE) data, which met market expectations. The headline PCE rose 2.7% year-over-year, and the core PCE, a key metric for the Federal Reserve, held steady at 2.9%. These in-line figures suggest the Fed is likely to maintain its cautious stance on future rate cuts, removing a potential near-term catalyst for a more aggressive market breakout. This sentiment is mirrored by the CNN Fear & Greed Index, which, at 52.8, remains firmly in the “Neutral” zone despite a marginal improvement. At the single-stock level, Intel Corp. (INTC) was a notable outperformer, surging over 4% on Friday to extend its weekly gain to around 20%. This powerful momentum is directly attributable to the persistent positive sentiment following Nvidia's announced $5 billion investment. Sector performance on Friday was broadly positive, led by materials and utilities, though a decline in consumer staples stocks indicated some investor selectivity.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment